Consensus Methods

This article explains four key areas growers should focus on to mitigate the need for excessive remediation.

As the industry continues to scale, more cannabis plants are being cultivated and processed than ever before to meet corresponding product demand, which in turn highlights the paramount role that GxP plays in ensuring the quality, safety, and efficacy of cannabis products.

A discussion on how extractors need to monitor the chemical processes they perform.

What does FDA oversight mean for cannabis businesses and the industry as a whole?

Highlights of the challenges facing the cannabis extracts industry and discussion about the need for standardized methods and the role of laboratory accreditation.

Here we examine the history of cannabis in the US, the role the USP played in that field, and the new role the USP is taking with cannabis for medical use.

What to consider when creating or using certified reference materials.

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.

An interview with Cynthia Ludwig

An interview with Susan Audino

An interview with Jeffrey C. Raber